InterventionsHumans32,236 participantsCohort study

Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study

Fig 1. Study design and methodology flowchart.
Open the figure at full size
Fig 1. Study design and methodology flowchart.Study design and methodology flowchart.Kazi et al.

PLOS One

The paper

Kazi MAI, Mufarrih SM, Sirohi A et al.

PLOS One · 24 Sep 2026

doi.org/10.1371/journal.pone.0358659PubMed 42784582

More on GLP-1 receptor agonists